ArticleBMC pregnancy and childbirth2026
Gestational diabetes in the pregnant Omani population in relation to their fatty acid intake and levels.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLow omega-3 Fatty acids (FAs) levels are associated with insulin resistance and upregulation of adiponectin and women with Gestational diabetes mellitus (GDM) have lower n-3 FAs. The current study assesses the association between FAs intake and individual fatty acid levels and ratios in maternal and cord erythrocyte FAs' profile GDM among sample of pregnant Arabic-speaking women in Oman. METHODOLOGY: This prospective cohort study was conducted among pregnant Omani women attending antenatal clinics in Al Buraimi, Oman, between 2019 and 2021. A subgroup of women diagnosed with gestational diabetes mellitus was compared with healthy pregnant controls. This analysis focuses on a subset of 56 women diagnosed with GDM compared to a control group of 101 healthy women. Seafood and the n-3 FAs intakes of women has been quantified by using a validated Food frequency questionnaire (FFQ). Maternal and cord blood FAs analysis of erythrocytes was carried out using the method of Folch et al.
resultsDHA and Omega-3 index (n-3 index) intake in the GDM population was significantly lower than in control group (p = 0.031) and (p = 0.05). GDM women had lower levels of Arachidonic acid (ArA) and Docosahexaenoic acid (DHA) (p = 0.002), total n-3 FAs (p = 0.001), but a higher level of lignoceric acid (24:00), Eicosapentaenoic acid EPA In term of cord erythrocytes, GDM women was significantly lower Adrenic acid LA, ArA, DHA, Adrenic acid (AdA), total n-6 FAs and EPA (p = 0.021) compared to the women in the control group.
conclusionsGDM women have a lower n-3 FAs intake reflected in their lower levels of erythrocyte membrane DHA. These findings provide the rationale for a randomized controlled trial of DHA replacement in pregnant women with low DHA levels to test the hypothesis that DHA replacement reduces the risk of developing GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.